Selank vs Semax at a glance
| Selank | Semax | |
|---|---|---|
| Also known as | anxiolytic nootropic | BDNF nootropic |
| Category | Cognitive & Neurological | Cognitive & Neurological |
| Format | SubQ / Intranasal | SubQ / Intranasal |
| Research level | Intermediate | Intermediate |
| Research sizes | 5 mg vial, 10 mg vial | 5 mg vial, 10 mg vial |
| In one line | A synthetic peptide studied for anxiolytic and cognitive research. | A synthetic peptide studied for cognition, focus, and neuroprotection research. |
What is Selank?
Selank is a synthetic heptapeptide derived from the immunomodulatory peptide tuftsin, developed in Russia. It is studied for anxiolytic (anti-anxiety) and cognitive endpoints without the sedation associated with classic anxiolytics.
Selank research focuses on modulation of GABAergic and monoamine signaling and on brain-derived neurotrophic factor (BDNF) expression, with interest in anxiety and focus endpoints.
What is Semax?
Semax is a synthetic heptapeptide derived from a fragment of adrenocorticotropic hormone (ACTH 4-10), developed in Russia. It is studied for cognitive and neuroprotective endpoints and is one of the most-cited nootropic research peptides.
Semax research focuses on up-regulation of BDNF and nerve-growth-factor signaling and on modulation of monoamine systems, with interest in learning, memory, and neuroprotection endpoints.
Key research differences
The two are best understood by what each is studied for. Selank: Selank is studied for anxiety endpoints where Semax is studied more for focus and BDNF; the two are complementary in cognitive research. Semax: Semax is studied more for focus and BDNF, Selank more for anxiety; N-Acetyl Semax Amidate is a more potent, longer-lasting analog.
How researchers choose between them
Because Selank and Semax both sit in the cognitive & neurological category, the choice is a research-design question: match the compound to the exact signal or endpoint your model targets, and in many protocols the two are studied in parallel or in sequence rather than as either/or. Whichever you select, compare on verified quality: both are third-party tested to a 99%+ purity target with a COA on request.
Frequently asked questions
What is the difference between Selank and Semax?
Selank is a synthetic peptide studied for anxiolytic and cognitive research, while Semax is a synthetic peptide studied for cognition, focus, and neuroprotection research. Both sit in the cognitive & neurological research category. Both are research-use-only. Selank: Selank is studied for anxiety endpoints where Semax is studied more for focus and BDNF; the two are complementary in cognitive research.
Can Selank and Semax be studied together?
Yes - within the same category they are often studied in parallel or sequence to compare or combine effects. Any combination work is laboratory research only. Semax: Semax is studied more for focus and BDNF, Selank more for anxiety; N-Acetyl Semax Amidate is a more potent, longer-lasting analog.
Which is better, Selank or Semax?
Neither is universally "better" - the right choice depends on the research question. Match the compound to your model's target signal, and compare suppliers on verifiable third-party purity, not sticker price. Selank is a synthetic heptapeptide derived from the immunomodulatory peptide tuftsin, developed in Russia.
What sizes are Selank and Semax supplied in?
Selank is supplied in 5 mg and 10 mg research sizes and Semax in 5 mg and 10 mg, both as lyophilized (freeze-dried) powder in sealed vials that are reconstituted in the lab before use in a liquid research model.
Are Selank and Semax FDA approved?
No. The research-grade Selank and Semax supplied here are not FDA-approved drug products; they are sold strictly for laboratory and in-vitro research. Where an approved pharmaceutical form of either compound exists, it is a separate prescription product made to clinical standards. Research material is not for human or animal consumption.
All comparisons · Selank · Semax · Selank cost
External references: Peptide (Wikipedia) · U.S. Food and Drug Administration